HOWL — WEREWOLF THERAPEUTICS INC

Ownership history in Lynx1 Capital Management LP  ·  1 quarter on record

This page tracks every 13F SEC filing in which Lynx1 Capital Management LP reported a position in WEREWOLF THERAPEUTICS INC (HOWL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.08% (2025 Q4)
Avg. % of fund
0.08%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 655,926 — — 0.08% $416K $0.63
% of Fund (quarterly)    HOWL price (monthly, adj. close)

Other funds also holding HOWL

As of 2025 Q4 — sorted by position size

DC Funds, LP 3Y 25.69% MPM BioImpact LLC 3Y 0.1% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 0.08% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.04% Ranch Capital Advisors Inc. 3Y 0.0% HIGHLINE WEALTH PARTNERS LLC 0.0% Regal Investment Advisors LLC 3Y 7Y 0.0% Delta Investment Management, LLC 3Y 7Y 0.0% Financial Perspectives, Inc 0.0% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0%
← Back to Lynx1 Capital Management LP Holdings